Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1960
http://purl.obolibrary.org/obo/NCIT_C1960
|
|---|---|
| Preferred Name | Girentuximab |
| Definitions |
A chimeric monoclonal antibody directed against G250, a cell surface antigen found in the majority of renal cell carcinomas. Following binding, monoclonal antibody G250 (mAb G250) may be internalized by G250 antigen-expressing renal carcinoma cells; mAb G250 may be useful as a carrier for radioisotopes and other antineoplastic therapeutic agents. (NCI05)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A chimeric monoclonal antibody directed against G250, a cell surface antigen found in the majority of renal cell carcinomas. Following binding, monoclonal antibody G250 (mAb G250) may be internalized by G250 antigen-expressing renal carcinoma cells; mAb G250 may be useful as a carrier for radioisotopes and other antineoplastic therapeutic agents. (NCI05) |
|---|---|
| prefLabel | Girentuximab
|
| label | Girentuximab
|
| PDQ_Closed_Trial_Search_ID | 373829
|
| code | C1960
|
| Has_Target | |
| prefixIRI | NCIT:C1960
|
| in_subset |
See more
See less
|
| Display_Name | Girentuximab
|
| Preferred_Name | Girentuximab
|
| FDA_UNII_Code | 539B57DFJF
|
| Contributing_Source |
CTRP
FDA
|
| Maps_To | Girentuximab
|
| CAS_Registry | 916138-87-9
|
| NCI_Drug_Dictionary_ID | 373829
|
| Legacy Concept Name | Monoclonal_Antibody_G-250
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 373829
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
Immunologic Factor
|
| UMLS_CUI | C0540128
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |